Eledon Pharmaceuticals, Inc. (ELDN) — Dilution Risk Analysis
Current Snapshot
Eledon Pharmaceuticals, Inc. (ELDN) has a DilutionWatch score of 51/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.
This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.
Dilution Risk Score
Score: 51/10 Source (as of 2026-10-03T03:45:52.527348)
Recent SEC Filings
1 shelf registration or ATM offering filing detected in recent history.
Recent filing forms in the source payload: S-3 1, XBRL 2.
| Form | Filed | Accession |
|---|---|---|
| S-3 | 2026-05-01 | 0001193125-26-201426 |
| xbrl | 2025-12-31 | xbrl-4997-xbrl_warrant |
| xbrl | 2016-12-31 | xbrl-4997-xbrl_convertible |
Dilution Risk Drivers
| Driver | Stored Value | Source |
|---|---|---|
| Shelf registration capacity | $500,000,000 | Source |
| Cash runway | 18 months | Source |
| Three-year share count growth | 235.82% | Source |
DilutionWatch Analysis
- Risk Level
- HIGH (Score: 51/10) Source
- Cash Runway
- 18 months Source
- Shelf Registration Capacity
- $500,000,000 Source
- Share Count Growth (3-Year)
- 235.82% Source
What This Page Does Not Estimate
DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.
Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.